» Articles » PMID: 9184857

Binding of Antibodies Against High and Low Molecular Weight Cytokeratin Proteins in the Human Placenta with Special Reference to Infarcts, Proliferation and Differentiation Processes

Overview
Journal Histochem J
Specialty Biochemistry
Date 1997 May 1
PMID 9184857
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Recent immunocytochemical studies have shown that placental villous trophoblasts contain the high molecular weight cytokeratin (CK) proteins 5/6 and 17. In the case of CK 17, trophoblastic immunostaining was positive in villi covered by fibrinoid. CKs 5/6 and 17 are expressed by hyperproliferative cells. The aim of this investigation was to examine the location of these CKs in placental infarcts, known to be demarcated by fibrinoid and hyperproliferative trophoblasts. The results were compared with those obtained by immunostaining against Ki-67, tenascin and alpha 1-, alpha 6- and beta 1-integrins, which are involved in cell proliferation, differentiation and regenerative processes. Furthermore, the expression of the single CKs 7, 8, 10, 13, 14, 18 and 19 was investigated by immunocytochemistry and immunoblotting. While low and high molecular weight CKs were present in villous and extravillous trophoblasts, only low molecular weight CKs were detected in vascular and extravascular placental smooth muscle cells. Placental infarcts revealed different immunoreactivities in the infarct margin and centre: high molecular CKs, tenascin, Ki-67 and oncofoetal fibronectin predominated in the infarct margin, low molecular CKs, fibrin and integrins in the centre. The expression of tenascin and a defined change in the expression of CK 17 indicates villous repair and hyperproliferative mechanisms in placental infarcts.

Citing Articles

HIF-1α Stabilization Increases miR-210 Eliciting First Trimester Extravillous Trophoblast Mitochondrial Dysfunction.

Anton L, DeVine A, Polyak E, Olarerin-George A, Brown A, Falk M Front Physiol. 2019; 10:699.

PMID: 31263422 PMC: 6590495. DOI: 10.3389/fphys.2019.00699.


Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection.

Gomez L, Anton L, Srinivas S, Elovitz M, Parry S Reprod Sci. 2018; 26(11):1449-1459.

PMID: 30572799 PMC: 6949957. DOI: 10.1177/1933719118820468.


Placental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsia.

Anton L, Olarerin-George A, Hogenesch J, Elovitz M PLoS One. 2015; 10(3):e0122707.

PMID: 25799546 PMC: 4370750. DOI: 10.1371/journal.pone.0122707.


Differential methylation of genes associated with cell adhesion in preeclamptic placentas.

Anton L, Brown A, Bartolomei M, Elovitz M PLoS One. 2014; 9(6):e100148.

PMID: 24963923 PMC: 4070941. DOI: 10.1371/journal.pone.0100148.


miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia.

Anton L, Olarerin-George A, Schwartz N, Srinivas S, Bastek J, Hogenesch J Am J Pathol. 2013; 183(5):1437-1445.

PMID: 24035613 PMC: 3814521. DOI: 10.1016/j.ajpath.2013.07.021.


References
1.
Damsky C, Fitzgerald M, Fisher S . Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest. 1992; 89(1):210-22. PMC: 442839. DOI: 10.1172/JCI115565. View

2.
Hynes R . Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992; 69(1):11-25. DOI: 10.1016/0092-8674(92)90115-s. View

3.
Mackay A, Tracy R, Craighead J . Cytokeratin expression in rat mesothelial cells in vitro is controlled by the extracellular matrix. J Cell Sci. 1990; 95 ( Pt 1):97-107. DOI: 10.1242/jcs.95.1.97. View

4.
Daya D, Sabet L . The use of cytokeratin as a sensitive and reliable marker for trophoblastic tissue. Am J Clin Pathol. 1991; 95(2):137-41. DOI: 10.1093/ajcp/95.2.137. View

5.
Korhonen M, Ylanne J, Laitinen L, Cooper H, Quaranta V, Virtanen I . Distribution of the alpha 1-alpha 6 integrin subunits in human developing and term placenta. Lab Invest. 1991; 65(3):347-56. View